查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571769

生物製藥製造消耗品測試的市場規模、佔有率和趨勢分析報告：按服務、按原料、按地區和細分趨勢：2024-2030

Biopharmaceuticals Manufacturing Consumables Testing Market Size, Share & Trends Analysis Report By Service (Laboratory, Custom), By Raw Material (Formulation Excipients, API), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

生物製藥製造消耗品測試市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計到2030年，全球生物製藥製造耗材檢測市場規模將達到12.7億美元，2024年至2030年複合年成長率為12.3%。

推動這一市場發展的是對原料深入評估的需求日益成長，以成功地將最終產品快速推向市場。對生物製藥行業內部標準和外部法規的認知不斷提高也推動了市場的成長。

近年來，發生了從小化學分子到生物大分子的重大模式轉移。因此，生物製藥行業正在朝著探索製造過程的各個方面的方向發展。

對最高品質原料和中間體的法規和品質期望不斷提高。這迫使賦形劑和原料製造商投資於標準化功能和複雜的工藝，以一致地滿足最終產品開發商的需求。

生物製藥製造消耗品測試市場報告亮點

  • 從服務來看，由於各個製造商對符合監管標準的原料的需求，藥典測試和多藥典測試佔據了最大佔有率。
  • 由於該領域存在廣泛的服務，原料藥（API）測試服務佔據了最大的銷售佔有率。
  • 2023年全球市場將由北美主導，因為美國有大量的生技藥品製造公司。市場參與企業之間的競爭加劇也是該地區佔據較大佔有率的因素。
  • 亞太地區預計將成為成長最快的區域市場，這主要是由於亞洲國家合約服務產業的擴張。部分原因是這些國家的營運成本較低。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章生物製藥製造消耗品測試市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 生物製藥製造耗材測試市場分析工具
    • 波特的分析
    • PESTEL分析

第4章生物製藥製造耗材測試市場：依服務估算及趨勢分析

  • 細分儀表板
  • 生物製藥製造消耗品測試市場：2023 年和 2030 年按服務分類的變化分析
  • 臨床檢查
  • 客自訂測試/客戶自己的測試
  • 藥典和多藥典考試

第5章生物製藥製造耗材測試市場：依原料估算及趨勢分析

  • 細分儀表板
  • 生物製藥製造耗材測試市場：2023年及2030年原料變化分析
  • 配方添加物
  • 活性藥物成分 (API)
  • 支援基於官方方法（USP/EP/JP）的供應商認證計劃

第6章生物製藥製造耗材測試市場：按地區估算及趨勢分析

  • 2023年及2030年生物製藥製造消耗品測試市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Alcami Corporation
    • Merck KGaA
    • Eurofins Scientific
    • Agilent Technologies, Inc.
    • Charles River Laboratories.
    • Catalent, Inc
    • Element Materials Technology（Avomeen Analytical Services）
    • Pace Analytical Services, LLC
    • Nelson Laboratories, LLC（Gibraltar Laboratories）
簡介目錄
Product Code: GVR-2-68038-398-0

Biopharmaceuticals Manufacturing Consumables Testing Market Growth & Trends:

The global biopharmaceuticals manufacturing consumables testing market size is expected to reach USD 1.27 billion by 2030, registering a CAGR of 12.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the growing need for an in-depth assessment of raw materials for the successful and rapid launch of the final product. Rising awareness pertaining to internal standards as well as external regulations in the biopharmaceutical industry is also aiding the market growth.

In the past few years, there has been a major paradigm shift from small chemical molecules to large biological molecules. As a result, the biopharmaceutical industry is geared toward exploring every aspect involved in the manufacturing process.

Regulatory and quality expectations for best quality raw materials and intermediates continue to increase. This, in turn, has pressurized vendors engaged in the manufacturing of excipients and raw materials to invest in standardizing functionality as well as establishing sophisticated processes to consistently address the needs of final product developers.

Biopharmaceuticals Manufacturing Consumables Testing Market Report Highlights:

  • Based on service, compendial and multi-compendial testing held the largest share owing to demand from various manufacturers for raw materials that are compliant to regulatory standards
  • Testing services for Active Pharmaceutical Ingredients (APIs) accounted for the largest revenue share owing to the presence of a wide range of services in this segment
  • Presence of a large number of biologics manufacturing entities in the U.S. has resulted in North America dominating the global market in 2023. Rising competitive rivalry amongst market participants is also attributive for the large share of this region
  • Asia Pacific is expected to emerge as the fastest-growing regional market, fueled primarily by expansion of the contract service industry in several Asian countries. This is partly attributed to low operating costs in these nations

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Biopharmaceuticals Manufacturing Consumables Testing Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Biopharmaceuticals Manufacturing Consumables Testing Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Biopharmaceuticals Manufacturing Consumables Testing Market: Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Biopharmaceuticals Manufacturing Consumables Testing Market: Service Movement Analysis, USD Million, 2023 & 2030
  • 4.3. Laboratory Testing
    • 4.3.1. Laboratory Testing Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
  • 4.4. Custom Testing / Customer Proprietary Testing
    • 4.4.1. Custom Testing / Customer Proprietary Testing Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
  • 4.5. Compendial & Multi Compendial Laboratory Testing
    • 4.5.1. Compendial & Multi Compendial Laboratory Testing Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)

Chapter 5. Biopharmaceuticals Manufacturing Consumables Testing Market: Raw Material Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Biopharmaceuticals Manufacturing Consumables Testing Market: Raw Material Movement Analysis, USD Million, 2023 & 2030
  • 5.3. Formulation Excipients
    • 5.3.1. Formulation Excipients Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
  • 5.4. Active Pharmaceutical Ingredients (API)
    • 5.4.1. Active Pharmaceutical Ingredients (API) Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)
  • 5.5. Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support
    • 5.5.1. Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support Market Revenue Estimates and Forecasts, 2018 -2030 (USD Million)

Chapter 6. Biopharmaceuticals Manufacturing Consumables Testing Market: Regional Estimates & Trend Analysis

  • 6.1. Biopharmaceuticals Manufacturing Consumables Testing Market Share, By Region, 2023 & 2030, USD Million
  • 6.2. North America
    • 6.2.1. North America Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 -2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Alcami Corporation
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Merck KGaA
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Eurofins Scientific
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Agilent Technologies, Inc.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Charles River Laboratories.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Catalent, Inc
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Element Materials Technology (Avomeen Analytical Services)
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Pace Analytical Services, LLC
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Nelson Laboratories, LLC (Gibraltar Laboratories)
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives